Search for other papers by Joseph Hirsch in
Current site
Google Scholar
PubMed
Search for other papers by Steven Mandel in
Current site
Google Scholar
PubMed
Search for other papers by Les Kertay in
Current site
Google Scholar
PubMed
Search for other papers by James B. Talmage in
Current site
Google Scholar
PubMed
Search for other papers by Greg Vanickachorn in
Current site
Google Scholar
PubMed
Search for other papers by Kurt Hegmann in
Current site
Google Scholar
PubMed
Search for other papers by James Underhill in
Current site
Google Scholar
PubMed
Search for other papers by John Meyers in
Current site
Google Scholar
PubMed
Search for other papers by Christopher R. Brigham in
Current site
Google Scholar
PubMed
Abstract
Post–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) conditions are referred to by a wide range of names, including long COVID, post-acute COVID-19, long-term effects of COVID, post-acute COVID syndrome, chronic COVID, long-haul COVID, late sequelae, and others, as well as the research term, post-acute sequelae of SARS-CoV-2 infection (PASC). Symptoms may include difficulty thinking or concentrating, fatigue, depression, anxiety, and other complaints. The results of studies are clouded by self-reports, lack of objective cognitive data, misattribution, and ill-defined psychological issues. Prospective cohort studies with objective assessment are needed to clarify the impact of COVID-19. While we do not dismiss the presence of long COVID or chronic COVID-19 symptoms lasting beyond a typically expected viral respiratory-transmitted syndrome, neither do we uncritically accept such a syndrome in all those who were diagnosed as having COVID-19, especially in those whose initial presentation was asymptomatic or mild. Evaluators must be astute and perform unbiased, thorough assessments and focus on objective findings while carefully assessing the potential for confounding or alternate conditions.
-
1.
Ramirez FE, Sanchez A, Pirskanen AT. Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19. Med Hypotheses. 2021;146:110363. doi: 10.1016/j.mehy.2020.110363.
-
2.
Centers for Disease Control and Prevention. Post–COVID Conditions: Information for Healthcare Providers. Updated July 9, 2021. Accessed April 27, 2022. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-COVID-conditions.html.
-
3.
World Health Organization. Post COVID-19 condition (Long COVID) [news release]. October 16, 2021. Accessed April 27, 2022. https://www.who.int/srilanka/news/detail/16-10-2021-post-covid-19-condition.
-
4.
American Medical Association. COVID-19 Update: Akiko Iwasaki, PhD, on the latest long COVID research [video interview]. Accessed May 14, 2022. https://youtu.be/lle9Tfhhfl4
-
5.
Pinnock FS, Rich JB, Vasquez B, et al.Neurocognitive outcome following recovery from severe acute respiratory syndrome - coronavirus-1 (SARS-CoV-1) [published online ahead of print, 2021 Sep 7]. J Int Neuropsychol Soc. 2021;1–11. doi: 10.1017/S1355617721001107.
-
6.
Mattioli F, Stampatori C, Righetti F, et al.Neurological and cognitive sequelae of Covid-19: a four month follow-up. J Neurol. 2021;268(12):4422–4428. doi: 10.1007/s00415-021-10579-6.
-
7.
Matta J. Wiernik E, Robineau O, et al.Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182(1):19. doi: 10.1001/jamainternmed.2021.6454.
-
8.
Taquet M, Geddes JR, Husain M, et al.6-Month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–427. doi: 10.1016/S2215-0366(21)00084-5.
-
9.
Whiteside DM, Basso MR, Naini SM, et al.Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection, part 1: cognitive functioning. Clin Neuropsychol. 2022; 8:1–23. doi: 10.1080/13854046.2022.2030412.
-
10.
RECOVER Builds Large Nationwide Study Population for Research on “Long COVID.” NIH Record. October 1, 2021;Vol LXXIII, No. 20. Accessed April 27, 2022. https://nihrecord.nih.gov/2021/10/01/recover-builds-large-nationwide-study-population-research-long-covid.
-
11.
Office for Civil Rights, Department of Health and Human Services. Guidance on “Long COVID” as a Disability Under the ADA, Section 503, and Section 1557. July 26, 2021. Accessed April 27, 2022. https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid19/guidance-long-covid-disability/index.html.
-
12.
Moghimi N, Di Napoli M, Biller J, et al.The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep. 2021;21(9):44. doi: 10.1007/s11910-021-01130-1.
-
13.
Yong SJ. Long COVID or post–COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737–754. doi: 10.1080/23744235.2021.1924397.
-
14.
Yoo SM, Liu TC, Motwani Y, et al.Factors associated with post-acute sequelae of SARS-COV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med. 2022;1–8. doi: 10.1007/s11606-022-07523-3.
-
15.
Hellgren L, Birberg Thornberg U, Samuelsson K, et al.Brain MRI and neuropsychological findings at long-term follow-up after COVID-19 hospitalisation: an observational cohort study. BMJ Open. 2021;11:e055164. doi: 10.1136/bmjopen-2021-055164.
-
16.
Nersesjan V, Fonsmark L, Christensen RHB, et al.Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non-COVID-19 illness. JAMA Psychiatry. 2022;79(5):486–497. doi: 10.1001/jamapsychiatry.2022.0284.
-
17.
Stavem K, Ghanima W, Olsen MK, et al.Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18(4):2030. doi: 10.3390/ijerph18042030.
-
18.
Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022; 604:697–707. doi: 10.1038/s41586-022-04569-5.
-
19.
Arnold DT, Hamilton FW, Milne A, et al.Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399–401. doi: 10.1136/thoraxjnl-2020-216086.
-
20.
Liu Y, Chen Y, Wang Q, et al.One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79(5):509–517. doi: 10.1001/jamaneurol.2022.0461.
-
21.
Sudre CH, Murray B, Varsavsky T, et al.Attributes and predictors of long COVID [published correction appears in Nat Med. 2021 Jun;27(6):1116]. Nat Med. 2021;27(4):626–631. doi: 10.1038/s41591-021-01292-y.
-
22.
Arica-Polat BS, Gündoğdu AA, Cinar N, et al.Evaluation of cognitive deficits in patients infected with COVID-19. Eur Rev Med Pharmacol Sci. 2022;26(2):678–685. doi: 10.26355/eurrev_202201_27894.
-
23.
Sklinda K, Dorobek M, Wasilewski PG, et al.Radiological manifestation of neurological complications in the course of SARS-CoV-2 infection. Front Neurol. 2021;12:711026. doi: 10.3389/fneur.2021.711026.
-
24.
Becker JH, Lin JJ, Doernberg M, et al.Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. 2021;4(10):e2130645. doi: 10.1001/jamanetworkopen.2021.30645.
-
25.
Sklinda K, Górecki A, Dorobek M, et al.Ischaemic background of brain fog in long haul COVID-19 – a nuclear magnetic resonance spectroscopy-based metabonomic analysis: preliminary results. Polish J Radiol. 2021;86(1):654–660. doi: 10.5114/pjr.2021b.111100.
-
26.
Zhao S, Shibata K, Hellyer PJ, et al.Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun. 2022;4(1):fcab295. doi: 10.1093/braincomms/fcab295.
-
27.
Gouraud C, Bottemanne H, Lahlou-Laforêt K, et al.Association between psychological distress, cognitive complaints, and neuropsychological status after a severe COVID-19 episode: a cross-sectional study. Front Psychiatry. 2021;12:1530. doi: 10.3389/fpsyt.2021.725861.
-
28.
Ferrucci R, Dini M, Groppo E, et al.Long-lasting cognitive abnormalities after COVID-19. Brain Sci. 2021;11:235. doi: 10.3390/brainsci11020235.
-
29.
García-Sánchez C, Calabria M, Grunden N, et al.Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. 2022;12(3):e2508. doi: 10.1002/brb3.2508.
-
30.
Hosp JA, Dressing A, Blazhenets G, et al.Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144(4):1263–1276. doi: 10.1093/brain/awab009.
-
31.
Michelen M, Manoharan L, Elkheir N, et al.Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427.
-
32.
Bungenberg J, Humkamp K, Hohenfeld C, et al.Long COVID-19: objectifying most self-reported neurological symptoms. Ann Clin Transl Neurol. 2022;9(2):141–154. doi: 10.1002/acn3.51496.
-
33.
Daroische R, Hemminghyth MS, Eilertsen TH, et al.Cognitive impairment after COVID-19: a review on objective test data. Front Neurol. 2021;12:699582. doi: 10.3389/fneur.2021.699582.
-
34.
Richman J, Green P, Gervais R, et al.Objective tests of symptom exaggeration in independent medical examinations. J Occup Environ Med. 2006;48(3):303–311. doi: 10.1097/01.jom.0000183482.41957.c3.
-
35.
Hane FT, Robinson M, Lee BY, et al.Recent progress in Alzheimer’s disease research, part 3: diagnosis and treatment. J Alzheimers Dis. 2017;57(3):645–665. doi: 10.3233/JAD-160907.
-
36.
Patel K, Robertson E, Kwong ASF, et al.Psychological distress before and during the COVID-19 pandemic among adults in the United Kingdom based on coordinated analyses of 11 longitudinal studies. JAMA Netw Open. 2022;5(4):e227629. doi: 10.1001/jamanetworkopen.2022.7629.
-
37.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.
-
38.
Whittaker R, Kemp S, House A. Illness perceptions and outcome in mild head injury: a longitudinal study. J Neurol Neurosurg Psychiatry. 2007;78:644–646.
-
39.
Hou R, Moss-Morris R, Peveler R, et al.When a minor head injury results in enduring symptoms: a prospective investigation of risk factors for postconcussional syndrome after mild traumatic brain injury. J Neurol Neurosurg Psychiatry. 2012;83:217–223.
-
40.
Snell DL, Hay-Smith EJC, Surgenor LJ, et al.Examination of outcome after mild traumatic brain injury: the contribution of injury beliefs and Leventhal’s common-sense model. Neuropsychol Rehabil. 2013;23:333–362.
-
41.
Lange RT, Iverson GL, Rose A. Post-concussion symptom reporting and the “good-old-days” bias following mild traumatic brain injury. Arch Clin Neuropsychol. 2010;25:442–450.
-
42.
Mittenberg W, DiGiulio DV, Perrin S, et al.Symptoms following mild head injury: expectation as aetiology. J Neurol Neurosurg Psychiatry. 1992;55:200–204.
-
43.
Gunstad J, Suhr JA. “Expectation as etiology” versus “the good old days”: postconcussion syndrome symptom reporting in athletes, headache sufferers, and depressed individuals. J Int Neuropsychol Soc. 2001;7:323–333.
-
44.
Ferguson RJ, Mittenberg W, Barone DF, et al.Postconcussion syndrome following sports-related head injury: expectation as etiology. Neuropsychol. 1999;13:582–589.
-
45.
Reidenberg M, Lowenthal D. Adverse nondrug reactions. N Engl J Med. 1968;279:678–9.
-
46.
Ihlebaek C, Eriksen HR, Ursin H. Prevalence of subjective health complaints (SHC) in Norway. Scand J Public Health. 2002;30:20–29.
-
47.
Iverson GL, Lange RT. Examination of “postconcussion-like” symptoms in a healthy sample. Appl Neuropsychol. 2003;10:137–144.
-
48.
Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259–264. doi: 10.1038/s41586-021-03553-9.
-
49.
Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with COVID-19: cohort study. BMJ. 2022;376:e068993. doi: 10.1136/bmj-2021-068993.
-
50.
Guo P, Benito Ballesteros A, Yeung SP, et al.COVCOG 2: cognitive and memory deficits in long COVID: a second publication from the COVID and Cognition Study. Front Aging Neurosci. 2022;14. doi: 10.3389/fnagi.2022.804937.
-
51.
Kanberg N, Simreén J, Edén A, et al.Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70:103512. doi: 10.1016/j.ebiom.2021.103512.
-
52.
Harris L, Griem J, Gummery A, et al; ENCEPH UK study group. Neuropsychological and psychiatric outcomes in encephalitis: a multi-centre case-control study. PLOS One. 2020;15(3):e0230436. doi: 10.1371/journal.pone.0230436.
-
53.
Munoz R, Cooper LA. The COVID-19 pandemic and mental health: implementing evidence-based interventions to advance equity and reverse a worsening crisis. JAMA Health Forum. 2022;3(4):e221282. doi: 10.1001/jamahealthforum.2022.1282.
-
54.
Berardelli I, Sarubbi S, Rogante E, et al.The impact of the COVID-19 pandemic on suicide ideation and suicide attempts in a sample of psychiatric inpatients. Psychiatry Res. 2021;303:114072. doi: 10.1016/j.psychres.2021.114072.
-
55.
Clemente-Suárez VJ, Martínez-González MB, Benitez-Agudelo JC, et al.The impact of the COVID-19 pandemic on mental disorders: a critical review. Int J Environ Res Public Health. 2021;18(19):10041. doi: 10.3390/ijerph181910041.
-
56.
Cooke JE, Eirich R, Racine N, Madigan S. Prevalence of posttraumatic and general psychological stress during COVID-19: a rapid review and meta-analysis. Psychiatry Res. 2020 Oct;292:113347. doi: 10.1016/j.psychres.2020.113347.
-
57.
Glowacz F, Schmits E. Psychological distress during the COVID-19 lockdown: the young adults most at risk. Psychiatry Res. 2020 Nov;293:113486. doi: 10.1016/j.psychres.2020.113486.
-
58.
Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services. 2020 National Survey of Drug Use and Health (NSDUH) Releases. Accessed November 11, 2021. https://www.samhsa.gov/data/release/2020-national-survey-drug-use-and-health-nsduh-releases.
-
59.
Meyers JE, Miller RM, Rohling ML, et al.Premorbid estimates of neuropsychological functioning for diverse groups. Appl Neuropsychol Adult. 2019;27(4):364–375. doi: 10.1080/23279095.2018.1550412.
-
60.
Meyers JE, Miller RM. Objective methods for matching neuropsychological patterns: formulas and comparisons. Appl Neuropsychol Adult. 2021;Jun 3:1–10. doi: 10.1080/23279095.2021.1929986.
-
61.
Fumagalli C, Zocchi C, Tassetti L, et al; AOU Careggi COVID-19 Follow-up study Group. Factors associated with persistence of symptoms 1 year after COVID-19: a longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med. 2022;97:36–41. doi: 10.1016/j.ejim.2021.11.018.
-
62.
Favreau M, Hillert A, Osen B, et al.Psychological consequences and differential impact of the COVID-19 pandemic in patients with mental disorders. Psychiatry Res. 2021 Aug;302:114045. doi: 10.1016/j.psychres.2021.114045.
-
63.
Xiong J, Lipsitz O, Nasri F, et al.Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020;277:55–64. doi: 10.1016/j.jad.2020.08.001.
-
64.
Dryden-Peterson S, Velásquez GE, Stopka TJ, et al.Disparities in SARS-CoV-2 testing in Massachusetts during the COVID-19 pandemic [published correction appears in JAMA Netw Open. 2021;4(4):e2110970]. JAMA Netw Open. 2021;4(2):e2037067. doi: 10.1001/jamanetworkopen.2020.37067.
-
65.
Hewitt KC, Marra DE, Block C, et al.Central nervous system manifestations of COVID-19: a critical review and proposed research agenda. J Int Neuropsychol Soc. 2022;28(3):311–325. doi: 10.1017/S1355617721000345.
-
66.
Caruso GM, Kertay L, Brigham CR. Evaluating post–COVID-19 conditions. Guides Newsletter. 2021;26(6):3–14. doi: 10.1001/amaguidesnewsletters.2021.NovDec01.
-
67.
Bryarly M, Phillips LT, Fu Q, et al.Postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2019;73(10):1207–1228. doi: 10.1016/j.jacc.2018.11.059.
-
68.
Fine JS, Ambrose AF, Didehbani N, et al.Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 2022;14(1):96–111. doi: 10.1002/pmrj.12745.
-
69.
Gulick SH, Mandel S, Maitz EA, et al.Cognitive screening tools. Guides Newsletter. 2021;26(3):3–7. doi: 10.1001/amaguidesnewsletters.2021.MayJune01.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 3335 | 3335 | 425 |
| Full Text Views | 46 | 46 | 0 |
| PDF Downloads | 0 | 0 | 0 |
